Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5860 posts found.

martin_shkreli_2016

Martin Shkreli ordered to forfeit $7.36m ahead of fraud sentencing

March 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Martin Shkreli, pharma

Reviled pharma bro Martin Shkreli is experiencing another heavy dose of karma after a US judge ordered him to forfeit …
News
dermira_logo

Dermira terminates acne drug after Phase 3 failure, wiping $667m from market value

March 5, 2018 Manufacturing and Production, Research and Development Dermira, acne, pharma, trial failure

Skin specialist biopharma firm Dermira has seen its stock crash and burn following the announcement that it plans to terminate …
News
shutterstock_141105490

Uncovering trends in the future of real world data

March 5, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, AstraZeneca, feature, pharma, real world data, real world evidence

A new report has canvassed the intentions of industry players in the use of real world data and evidence over …
Feature

FDA finds major manufacturing issues at key Aurobindo facility

March 5, 2018 Manufacturing and Production, Sales and Marketing Aurobindo, FDA, pharma

Indian pharmaceutical firm Aurobindo has been rocked by an USFDA review which identified nine major issues with its Unit 4 …
News
top_ten

Top Ten most popular articles on Pharmafile.com this week

March 2, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Alzheimer's, AstraZeneca, Botox, Celgene, EMA, FDA, Merck, Mylan, Pfizer, Roche, Takeda, ipsen, vaccines

We’re already into March and, trying to put a bad start to the year behind them on Alzheimer’s research, the …
News
david_meek_web

Ipsen: Becoming a “development powerhouse”

March 1, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Meek, Insider Interview, ipsen, pharma

Immediately following the release of impressive full year financials, Ipsen CEO David Meek speaks on how the company is hitting …
Feature
takeda_usa_pharmaceuticals_u

Takeda to create 70 jobs with €25m Dublin investment

March 1, 2018 Manufacturing and Production Dublin, Takeda, pharma

Takeda has announced its investment of €25 million to construct a new “modular cell therapy facility dedicated to manufacturing a …
News
pharmafocus_march_2018_cover

Pharmafocus March 2018 is available to read online now!

February 28, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, brexit, drug safety, pharma, real world data

Though never truly out of vogue, the drug pricing debate has flared up again with the White House’s release of …
News
nhs_sign

UK Government announces prescription price hike to record level

February 27, 2018 Manufacturing and Production, Medical Communications, Sales and Marketing NHS, pharma, prescription, price

The UK Government has announced plans to increase prescription charges by 20p, or 2.3%, to a record £8.80, effective 1 …
News

Allergan’s patent gamble fails

February 27, 2018 Manufacturing and Production, Medical Communications Allergan, Mylan, biotech, drugs, patent, pharma, pharmaceutical

Allergan’s patent deal with the Saint Regis Mohawk Tribe, in an attempt to protect itself from an inter partes review …
News
opioid_crisis

FDA to fight opioid crisis with wider access to medication-assisted treatment

February 27, 2018 Manufacturing and Production, Medical Communications, Research and Development Alex Azar, FDA, medication-assisted treatment, opioid crisis, opioids, pharma

The FDA is set to refocus its efforts in combating the United States’ opioid crisis. Speaking at a meeting of …
News
vaccination-2722937_960_720

UK govt report looks to reduce vaccination spending

February 27, 2018 Manufacturing and Production, Medical Communications Vaccine, biotech, drugs, meningitis, pharma, pharmaceutical

One of the largest petitions ever to have gone before UK parliament, after it attracted 823,349 signatures, brought about the …
News

FDA expands indication of Lilly’s Verzenio in advanced breast cancer

February 27, 2018 Manufacturing and Production, Sales and Marketing Cancer, Eli Lilly, FDA, Verzenio, breast cancer, pharma

Eli Lilly is celebrating the news that its cyclin-dependent kinase (CDK) 4 & 6 inhibitor Verzenio (ademaciclib) has received approval …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 23, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Alzheimer's, AstraZeneca, Eylea, FDA, Microsoft, Regeneron, Shire, Tremfya, eurordis, multiple myeloma, rare disease

It’s the last Friday of February, and it’s time for another run-down of the most popular stories of the week. …
News
aaa

Insider Interview: Allergan’s R&D Chief on plans to be “the headache company”

February 22, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, David Nicholson, Insider Interview, migraine, pharma

Speaking to Pharmafocus , David Nicholson, Chief R&D Officer at Allergan, revealed that the company has big plans in the …
Feature
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026